Medivate Partners

Medivate Partners is a private equity firm founded in 2012, specializing in cross-border investments within the life sciences sector. The firm focuses on companies in the biotechnology and pharmaceutical industries, aiming to support the growth and development of innovative healthcare solutions. Medivate Partners has raised approximately $80 million in capital, investing in five portfolio companies, including clinical-stage biotech firms and contract development manufacturing organizations (CDMOs).

The firm's investment strategy emphasizes value investing, leveraging strategic partnerships to enhance the success of its portfolio companies. Medivate Partners has a proven track record in the life sciences industry, providing competitive advantages through its management team's expertise and established relationships. This approach has contributed to the firm's reputation as one of the first private equity firms in Korea with expertise in cross-border healthcare investments.

Medivate Partners' portfolio includes notable companies such as Cognate BioServices, a leading contract development and manufacturing organization for cell and gene therapy products, and Genopis Inc., a pharmaceutical company acquired by Wacker Chemie AG in 2021. These investments highlight the firm's commitment to advancing healthcare through strategic partnerships and value-driven investments.